PHCEU previewing new CO2 incubator and Twinguard freezer at CAR-TCR Europe
Press Release | PHC Europe BV
FEBRUARY 13, 2019
Etten-Leur, The Netherlands: – Biomedical preservation specialist PHC Europe B.V. (PHCEU), will be a high profile presence at the upcoming CAR- TCR Europe summit in London dedicated to Chimeric Antibody Receptor and genetically modified T Cell Receptor based immunotherapies for cancer.
PHCEU will be an exhibitor at the summit, previewing two new PHCbi branded products with high relevance to the cell therapy sector; the MDF-DU502VX Twinguard ULT freezer and MCO-170AICUVD CO2 Incubator.
Presence in immunotherapy
Tim Smith and Alex Raha from PHCEU’s UK sales team will represent PHC Europe at the CAR -TCR summit in London.
“We are looking forward to this great event, having attended previous CAR-TCR summits in the USA,” commented PHCEU Marketing Manager, Arthur Goudena.
“PHCEU has a big presence in European cell therapy and immunotherapy research, which makes intensive use of so many of our PHCbi preservation, incubation, processing and sterilization products,” Mr. Goudena added.
Netherlands-based PHC Europe BV (PHCEU) is the European and African arm of the international PHC Corporation, whose PHCbi products are recognized worldwide as a leading and trusted brand for reliable, high-quality medical and laboratory equipment, with particular focus on technologies for preservation, incubation, sterilization and healthcare.
The company’s mission is to provide a leading, trusted brand for sustainable healthcare and biomedical product solutions, supporting the work of its customers to improve the health and well-being of people around the world.
PHCEU solutions range from excellent sample security in an ultra-low temperature (ULT) freezer or the best environment for cell culture in a CO2 incubator, while its relationships span the pharmaceutical, healthcare and biotechnology sectors, with a pan-continental supply and support network that can quickly meet customer demands across Europe and Africa.
PHCbi products are grouped in four main ranges: Preservation, Incubation, Processing and Sterilization and include ULT, cryogenic and biomedical Freezers, pharmaceutical and blood bank refrigerators, liquid nitrogen cryopreservation freezers, lab tanks, transport containers and vapor shippers and a range of incubation and sterilization solutions.
PHCEU is part of the international PHC Corporation, founded in Japan in 1969, that now operates across more than 120 countries worldwide, focusing on the three core business fields of Medical Devices, Healthcare IT & Life Sciences.
PHC products and facilities are certified to ISO 9001, ISO 14001 and ISO 13485 standards for quality, environmental management and medical devices.
PHC can provide turnkey solutions for validation and qualification in accordance with all current GMPs, GLPs, GCPs, 21 CFR Part 11, PAT, ISO and specific customer requirements and applications.
About CAR-TCR Europe
First run in 2018, the CAR-TCR Europe Summit is dedicated to the development and delivery of next generation Chimeric Antibody Receptor (CAR) and genetically modified T Cell Receptor (TCR) based immunotherapies for cancer.
The summit is a knowledge sharing and networking event that features a multi-track conference program, featuring more than 40 speakers, plus interactive forums.
The 2019 summit is a three-day event opening February 25 at the Novotel West London hotel and conference center. It is expected to attract more than 250 delegates.
The CAR-TCR series of summits is organized by Hanson Wade with further information at: www.cartcr-europe.com/
Arthur Goudena, Marketing Manager, PHC Europe
Tel: +31 70 3010029